组件结构排列对胆固醇抗原结合体免疫性和抗血清杀菌活性对A组链球菌的影响
Mariusz Skwarczynski1, Nedaa Alharbi2, Ummey J Nahar1
1School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD 4072, Australia.
Bioorganic chemistry
|February 14, 2025
概括
结合胆固醇的疫苗显示出强烈的免疫反应对A组链球菌. 这些新型疫苗是自我辅助的,消除了对额外免疫刺激剂的需求.
科学领域:
- 疫苗学 疫苗学 疫苗学
- 免疫学 免疫学 免疫学
- 生物结合化学 生物结合化学
背景情况:
- 辅助剂对于疫苗的疗效至关重要,但临床上批准的选择是有限的,通常来自病原体.
- 胆固醇是一种天然存在的人体脂质,为辅助剂的开发提供了替代方案.
研究的目的:
- 为了研究与抗原结合的胆固醇的辅助潜力.
- 评估线性和分支胆固醇结合物的结构-活性关系.
- 在小鼠模型中评估基于胆固醇的疫苗的免疫性和有效性.
主要方法:
- 胆固醇与A组链球菌 (GAS) M蛋白衍生的J8 B细胞表皮和P25 T细胞表皮的结合.
- 结构-活性关系研究,比较线性和分支联.
- 评估脂质体配方和给药途径 (皮下,鼻内).
- 对GAS临床分离物的抗体生产和杀菌能力的评估.
主要成果:
- 胆固醇-P25-J8合物通过皮下和鼻内给药诱导了最高的抗体产生.
- 线性胆固醇疫苗引起了强大的抗体反应,有效地对抗GAS.
- 疫苗免疫性受到结合元件的结构安排的显著影响.
- 胆固醇结合物表现出自我辅助的特性,诱导免疫反应没有外源辅助剂.
结论:
- 基于胆固醇的联是一种有前途的自我辅助疫苗平台.
- 线性胆固醇结合物有效地引起强烈的,保护性免疫反应对GAS.
- 这种方法为开发更安全,更有效的疫苗辅助剂提供了一个新的策略.
更多相关视频
08:47Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens
Published on: April 5, 2019
12.1K
12:53Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
Published on: March 16, 2022
1.6K
相关概念视频
Antibody Actions
1.0K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.0K
Antigens Involved in Adaptive Immunity
438
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
438
Antibody Structure
58.8K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
58.8K
Antibody Structure and Classes
737
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
737
Cross-reactivity
30.9K
Overview
30.9K
Vaccinations
43.8K
Overview
43.8K
